INmune Bio enters warrant inducement; reduces exercise price to $1.40, extends maturity to Dec 2027

Inmune Bio, Inc.

Holders exercise 647,112 warrants at reduced price of $1.40/share (from $1.95), generating $905,957 in cash.
Remaining 50% of April 2024 warrants have maturity extended from June 30, 2026 to December 31, 2027.
Warrant exercise and amendment executed via Inducement Letter and Second Amendment on June 30, 2026.
Shares underlying warrants are registered under effective registration statement (File No. 333-279036).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.